Jw Pharmac (001060) - Total Liabilities
Based on the latest financial reports, Jw Pharmac (001060) has total liabilities worth ₩235.90 Billion KRW (≈ $159.87 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Jw Pharmac - Total Liabilities Trend (2000–2025)
This chart illustrates how Jw Pharmac's total liabilities have evolved over time, based on quarterly financial data. See Jw Pharmac short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Jw Pharmac Competitors by Total Liabilities
The table below lists competitors of Jw Pharmac ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Central Garden & Pet Company
NASDAQ:CENT
|
USA | $2.07 Billion |
|
Shenzhen HeKeda Precision Cleaning Equipment Co Ltd
SHE:002816
|
China | CN¥222.77 Million |
|
Microvast Holdings Inc
NASDAQ:MVST
|
USA | $521.39 Million |
|
ShaMaran Petroleum Corp
V:SNM
|
Canada | CA$202.99 Million |
|
Shandong Synthesis Electronic Technology Co Ltd
SHE:300479
|
China | CN¥950.14 Million |
|
China Railway High speed Electrification Equipment Co Ltd
SHG:688285
|
China | CN¥1.32 Billion |
|
Plasson Indus
TA:PLSN
|
Israel | ILA989.96 Million |
Liability Composition Analysis (2000–2025)
This chart breaks down Jw Pharmac's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Jw Pharmac worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.42 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.64 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jw Pharmac's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jw Pharmac (2000–2025)
The table below shows the annual total liabilities of Jw Pharmac from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩235.90 Billion ≈ $159.87 Million |
-14.25% |
| 2024-12-31 | ₩275.11 Billion ≈ $186.44 Million |
-27.53% |
| 2023-12-31 | ₩379.60 Billion ≈ $257.25 Million |
-5.62% |
| 2022-12-31 | ₩402.21 Billion ≈ $272.57 Million |
-9.52% |
| 2021-12-31 | ₩444.51 Billion ≈ $301.24 Million |
+30.12% |
| 2020-12-31 | ₩341.62 Billion ≈ $231.51 Million |
-0.44% |
| 2019-12-31 | ₩343.12 Billion ≈ $232.52 Million |
+2.83% |
| 2018-12-31 | ₩333.68 Billion ≈ $226.13 Million |
-7.34% |
| 2017-12-31 | ₩360.10 Billion ≈ $244.03 Million |
-3.91% |
| 2016-12-31 | ₩374.76 Billion ≈ $253.97 Million |
-3.43% |
| 2015-12-31 | ₩388.07 Billion ≈ $262.99 Million |
+4.80% |
| 2014-12-31 | ₩370.29 Billion ≈ $250.94 Million |
-4.72% |
| 2013-12-31 | ₩388.63 Billion ≈ $263.37 Million |
-11.57% |
| 2012-12-31 | ₩439.48 Billion ≈ $297.83 Million |
-11.54% |
| 2011-12-31 | ₩496.84 Billion ≈ $336.70 Million |
+44.69% |
| 2006-12-31 | ₩343.37 Billion ≈ $232.70 Million |
-4.23% |
| 2005-12-31 | ₩358.53 Billion ≈ $242.97 Million |
+6.02% |
| 2004-12-31 | ₩338.16 Billion ≈ $229.17 Million |
+12.95% |
| 2003-12-31 | ₩299.40 Billion ≈ $202.90 Million |
+5.10% |
| 2002-12-31 | ₩284.88 Billion ≈ $193.06 Million |
-3.88% |
| 2001-12-31 | ₩296.37 Billion ≈ $200.84 Million |
-5.01% |
| 2000-12-31 | ₩311.99 Billion ≈ $211.43 Million |
-- |
About Jw Pharmac
JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam steri… Read more